Professor , specializing in diabetic nephropathy and hypertensive nephropathy
Urology
Research focus: Clinical diagnosis and treatment of primary and secondary kidney diseases, with a focus on diabetic nephropathy and hypertensive nephropathy. Cutting-edge technology: Primarily engaged in the clinical diagnosis and treatment of various primary and secondary kidney diseases, specializing in the treatment of refractory nephrotic syndrome, IgA nephropathy, membranous nephropathy, lupus nephritis, and other diseases. Diseases specializing in: refractory nephrotic syndrome, IgA nephropathy, mem
Affiliated Hospital
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
→
Former Director of Radiology Department, Professor/Doctoral Supervisor, President of the Asian Society of Abdominal Radiology
Urology
Research areas : Abdominal imaging diagnosis (liver, gallbladder, pancreas, spleen, gastrointestinal tract, portal venous system); early screening, diagnosis, and prognostic classification of liver cancer. Cutting-edge technologies: The "West China Solution" for early screening and diagnosis of liver cancer using imaging (a new standard for liver cancer diagnosis and a screening model for high-risk groups based on MR functional imaging); a new multimodal imaging prognostic classification for liver cancer;
Affiliated Hospital
West China Hospital of Sichuan University
→
Chief Physician, Associate Professor, Master's Supervisor, Deputy Director of Nephrology, and Head of the CRRT Subspecialty Group
Urology
-Research areas : complications of hemodialysis, acute kidney injury and critical blood purification technology; CRRT anticoagulation technology. - Cutting-edge technologies: individualized CRRT dosage for severe cases, early warning model for critical AKI, and the world's first local citrate anticoagulation technology with calcium-containing replacement fluid; comprehensive treatment for severe AKI. - Areas of expertise: ICU severe acute kidney injury, septic kidney injury, renal replacement therapy for
Affiliated Hospital
West China Hospital of Sichuan University
→
Associate Chief Physician, PhD, Deputy Director of the Department of Nuclear Medicine
Urology
-Research areas : Molecular imaging of tumors, PSMA PET assessment of prostate cancer; - Areas of expertise: Ga-PSMA PET/CT image analysis, lesion interpretation, and semi-quantitative assessment of PSMA expression; - Areas of expertise: Initial staging of prostate cancer, biochemical recurrence localization, and RLT efficacy evaluation; - Academic Highlights & Core Values: Backbone in molecular imaging for prostate cancer, involved in multicenter clinical studies related to PSMA, and optimized PSMA imagi
Affiliated Hospital
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
Chief Physician, Master's Supervisor, Deputy Director of Nephrology, and Head of the Vascular Access Subspecialty Group.
Urology
Research areas : Hypertensive nephropathy, gouty nephropathy, urinary tract infections, and establishment and maintenance of hemodialysis access. Cutting-edge technologies: Over 5000 arteriovenous fistula surgeries have been performed, with a primary patency rate of 92% one year post-surgery; innovative ultrasound-guided balloon dilation has been used to treat fistula stenosis, avoiding secondary surgical trauma for patients; RAAS blockers combined with uric acid management have been applied to hypertensi
Affiliated Hospital
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
Chief Physician, Professor, Doctoral Supervisor, Chief Expert of Renji Hospital, Director of the Department of Internal Medicine, and Academic Leader of Nephrology.
Urology
Research Areas : Diagnosis and treatment of various primary and secondary complex and critical kidney diseases, especially lupus nephritis, diabetic nephropathy, IgA nephropathy, and acute and chronic renal failure. Cutting-Edge Technologies: Pioneered the implementation of a combined assessment model of renal pathology, clinical practice, and molecular subtyping in China, significantly improving the remission rate of IgA nephropathy and lupus nephritis; led the construction of the first home dialysis tra
Affiliated Hospital
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
Chief Physician, Doctoral Supervisor, Director of the Department of Nuclear Medicine
Urology
-Research areas : PSMA diagnosis and treatment integration, prostate cancer molecular imaging, and radioligand translational research. - Cutting-edge technologies: ¹⁸F-PSMA PET/MR imaging system; ¹⁷⁷Lu-PSMA target screening and dose assessment. - Areas of expertise: PSMA molecular imaging assessment for prostate cancer, ¹⁷⁷Lu-PSMA radioligand therapy for advanced prostate cancer, and radionuclide therapy for thyroid cancer. - Academic Highlights: Contributing expert to the "Expert Consensus on the
Affiliated Hospital
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
Chief Physician, Doctoral Supervisor, currently serving as Director of the Department of Urology, and named one of Shanghai's "Most Beautiful Medical Workers" in 2025.
Urology
Research Areas : Surgical treatment of early-stage prostate tumors and individualized comprehensive treatment of advanced prostate cancer, with a focus on the early metastasis mechanisms of prostate cancer. Cutting-Edge Technologies: Proficient in da Vinci robot-assisted laparoscopic radical prostatectomy, specializing in surgery for locally advanced prostate cancer and salvage lymph node dissection after radical prostatectomy; utilizes apheresis liquid biopsy technology to significantly improve the throu
Affiliated Hospital
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
Director of Radiology Department, Chief Physician, Professor/Doctoral Supervisor, National High-Level Talent
Urology
Research areas : imaging of cerebrovascular diseases and brain tumors; artificial intelligence in medical imaging; psychiatric imaging and its clinical translation; neuropsychiatric radiological diagnosis. Cutting-edge technologies: brain perfusion, functional magnetic resonance imaging of the brain, brain tumor radiomics, AI brain lesion identification; the world's first "Psychoradiology"; leading the development of the first Chinese guidelines for the standardized application of MR brain structural imag
Affiliated Hospital
West China Hospital of Sichuan University
→
Chief Physician, Party Secretary of Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, and Chief Physician of the Department of Nephrology.
Urology
Research Areas : Clinical and research work in acute kidney injury, chronic kidney disease, and kidney transplantation, with particular expertise in the integrated traditional Chinese and Western medicine approach to the prevention and treatment of acute and chronic kidney diseases and their complications. Cutting-Edge Technologies: Focusing on the mechanism of renal fibrosis following acute kidney injury and other related translational medicine research in kidney diseases; in 2024, in collaboration with
Affiliated Hospital
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
Professor , specializing in nephrotic syndrome and immunosuppression in kidney transplantation
Urology
Research areas: Diagnosis and treatment of primary and secondary glomerular diseases, renal vascular diseases, and acute and chronic renal failure. Cutting-edge technology: Unique research achievements in nephrotic syndrome, IgA nephropathy, lupus nephritis, and immunosuppressive therapy for kidney transplant rejection. Regularly organizes national training courses on "Clinical Diagnosis and Treatment of Nephrology at Peking Union Medical College Hospital," promoting the nationwide dissemination of nephro
Affiliated Hospital
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
→
Chief Physician, Doctoral Supervisor
Urology
-Research areas : radionuclide therapy internal radiation dosimetry, organ radiation protection with radioligands, and tumor radionuclide targeted therapy. - Cutting-edge technologies:¹⁷⁷Lu-PSMA SPECT/CT absorbed dose calculation; kidney and bone marrow radiation damage prediction models. - Areas of expertise: Treatment of mCRPC¹⁷⁷Lu-PSMA, radionuclide therapy for differentiated thyroid cancer, and radionuclide analgesia for bone metastases of tumors. - Academic Highlights: Member of the Radionuclid
Affiliated Hospital
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
Chief Physician, Level 2 Professor, Doctoral Supervisor, Former Department Director, Expert Receiving Special Allowances from the State Council.
Urology
Research Areas : Diagnosis and treatment of urogenital tumors, with particular expertise in the diagnosis and treatment of VHL hereditary renal cell carcinoma, nephron-sparing surgery for renal tumors, and surgery for renal cell carcinoma with vena cava tumor thrombus. Cutting-Edge Technologies: The team pioneered laparoscopic partial nephrectomy, significantly reducing the probability of postoperative renal function impairment; actively promoting the MDT (Multidisciplinary Team) treatment model, signific
Affiliated Hospital
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
Assistant Director of Nuclear Medicine Department, Chief Physician, Doctoral Supervisor
Urology
Research areas: Nuclear medicine imaging diagnosis, especially PET/CT, and molecular imaging diagnosis of rare tumors and endocrine tumors. Cutting-edge technologies: We have created an official WeChat account, "Peking Union Medical College Hospital Nuclear Medicine," to promote the popularization and exchange of knowledge about nuclear medicine imaging diagnosis. We are conducting research on the application of the novel Ga-DOTA-CCK-FS imaging technology for the diagnosis of medullary thyroid carcinoma a
Affiliated Hospital
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
→
Research areas : acute and chronic rejection of kidney transplantation; drug concentration monitoring and chronic transplant nephropathy. Areas of expertise: Post-kidney transplant management, various primary and secondary kidney diseases, chronic kidney disease, and follow-up management of hemodialysis patients. Academic Highlights: Core expert in transplant kidney nephropathy and drug concentration monitoring.
Affiliated Hospital
West China Hospital of Sichuan University
→
Doctor, physician, associate researcher, master's supervisor.
Urology
Research Areas : Multimodal diagnosis, differential diagnosis, and target-specific integrated diagnosis and therapy for malignant tumors; basic research and clinical translational application of integrated diagnostic and therapeutic antibody probes. Cutting-Edge Technologies: Long-term commitment to the basic research and clinical translational application of integrated diagnostic and therapeutic antibody probes; creation of a series of monoclonal antibodies and single-domain antibody probes with complete
Affiliated Hospital
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
Chief Physician, Professor, Head of Urinary Continence and Pelvic Floor Subspecialty
Urology
-Research areas : urinary dysfunction, female pelvic floor disorders, interstitial cystitis; - Areas of expertise: Sacral nerve electrical stimulation (bladder pacemaker) implantation, TVT urinary incontinence sling minimally invasive procedure; - Areas of expertise: Stress urinary incontinence, neurogenic bladder, refractory interstitial cystitis, vesicovaginal fistula; - Academic Highlights & Core Values: A leading expert in sacral nerve modulation in China, the first to create 3D navigation template pu
Affiliated Hospital
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
Deputy Director of Nuclear Medicine Department, Chief Physician, Professor, Postdoctoral Supervisor
Urology
Research areas: Comprehensive treatment and full-course management of thyroid cancer; treatment and molecular evolution mechanism of hypodifferentiated and undifferentiated thyroid carcinoma; integration of novel molecular probes with tumor diagnosis and treatment. Cutting-edge technology: Pioneered internationally in applying RGD-type molecular probes reflecting tumor angiogenesis to localize iodine-refractory thyroid cancer; led domestic clinical trials of the proprietary targeted drugs apatinib and don
Affiliated Hospital
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
→
Deputy Director of the General Office of the Clinical Research Institute, Chief Physician of the Department of Nuclear Medicine, and Professor.
Urology
Research areas: Clinical diagnostic applications of PET/CT and related basic clinical research; radiopharmaceutical development and clinical translation. Cutting-edge technologies: Leading the development of the innovative EB-PSMA-17 drug, extending the drug's half-life and improving tumor uptake and retention through Evans blue (EB) structural modification. Leading the completion of a nationwide multicenter clinical trial (11 tertiary hospitals, 409 clinical trial participants) of the "world's first" rad
Affiliated Hospital
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
→
Professor specializing in complex and critical kidney diseases and complications of chronic kidney disease.
Urology
Research areas: Diagnosis and treatment of primary and secondary glomerular diseases, renal vascular diseases and acute and chronic renal failure, and prevention and treatment of complications of chronic kidney disease. Cutting-edge technology: Led the "Prevention and Treatment of Complications of Chronic Kidney Disease" project, conducting the first cross-sectional and related factor study on cerebrovascular lesions and cognitive function in hundreds of uremia patients from different populations in my co
Affiliated Hospital
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
→
PhD, Associate Chief Physician, Master's Supervisor, Vice Dean of the Institute of Molecular Medicine, Shanghai Jiao Tong University School of Medicine, and Associate Chief Physician of the Department of Nuclear Medicine, Renji Hospital.
Urology
Research Areas : Development and clinical translation of novel nuclear medicine molecular probes. Cutting-Edge Technologies: Long-term experience in clinical practice, research, and teaching in nuclear medicine, with a focus on the development and clinical translation of novel nuclear medicine molecular probes. Systematic work has been conducted in the development and clinical translation of prostate cancer-specific molecular probes. Areas of Expertise: Nuclear medicine molecular imaging diagnosis, clinic
Affiliated Hospital
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
Chief Physician, Professor, Head of the Bladder Tumor Specialty Group.
Urology
Research Areas : Personalized treatment and comprehensive treatment guided by molecular subtyping for bladder cancer. Cutting-edge Technologies: Pioneered in China completely laparoscopic orthotopic neobladder resection and da Vinci robot-assisted total cystectomy; based on molecular subtyping, chemotherapy, immunotherapy, or surgical options are selected, increasing the conversion resection rate of advanced bladder cancer to 75%. Areas of expertise: Muscle-invasive bladder cancer, high-risk non-invasive
Affiliated Hospital
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
Chief Physician, Professor, Doctoral Supervisor, Head of Andrology Subspecialty
Urology
-Research areas : Male infertility, erectile dysfunction, urethral and external genital plastic surgery; - Areas of expertise: penile prosthesis implantation, microsurgical urological surgery, complex urethral reconstruction; - Areas of expertise: Severe erectile dysfunction, obstructive azoospermia, urethral stricture, penile defects and deformities; - Academic Highlights & Core Values: Core expert of Shanghai Institute of Andrology, a leading authority in microscopic andrology and male genital reconstru
Affiliated Hospital
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
Chief Physician, Level 2 Professor, Doctoral Supervisor, Director of Nephrology Department, and Director of the Nephrology Research Institute
Urology
-Research areas : Diabetic nephropathy, severe acute kidney injury, blood purification, large-scale cohort studies of chronic kidney disease, pathogenesis and prevention of metabolic kidney diseases (with a focus on diabetic nephropathy, hypertensive nephropathy, and hyperuricemic nephropathy); various primary and secondary kidney diseases; acute and chronic renal failure. - Cutting-edge technologies: Simplified citrate anticoagulation CRRT, CKD three-in-one follow-up management system, construction and p
Affiliated Hospital
West China Hospital of Sichuan University
→
PhD, Associate Chief Physician, Head of the Radionuclide Therapy Subspecialty Group.
Urology
Research Areas : Integrated clinical and research work in nuclear medicine and radionuclide diagnosis and therapy; research on the intracellular retention mechanism of PSMA ligands in prostate cancer and strategies for enhancing the efficacy of PSMA-RLT. Cutting-Edge Technologies: Long-term experience in integrated clinical, research, and teaching work in nuclear medicine and radionuclide diagnosis and therapy; presented a report at the 2nd CSCO Annual Meeting on "Exploring the Intracellular Retention Mec
Affiliated Hospital
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
Chief Physician, Level 2 Professor, Doctoral Supervisor, Vice President of Renji Hospital.
Urology
Research areas : Comprehensive diagnosis and treatment of renal tumors, surgical management of renal cell carcinoma with inferior vena cava tumor thrombus, and basic and clinical research on renal transplant rejection and pathological damage. Cutting-edge technologies: Successfully developed and commercialized kidney and multi-organ preservation solutions, filling a domestic gap; conducted extensive forward-looking and landmark work in the areas of renal transplant rejection, pathological damage, and pre-
Affiliated Hospital
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
Chief Physician, Doctoral Supervisor, Deputy Director of Nephrology Department.
Urology
Research Areas : Diagnosis and treatment of various chronic kidney diseases, including proteinuria, hematuria, nephrotic syndrome, renal failure, membranous nephropathy, IgA nephropathy, lupus nephritis, and diabetic nephropathy, as well as peritoneal dialysis treatment for uremia. Cutting-Edge Technologies: As a core faculty member of the Ministry of Health's Peritoneal Dialysis Training Center, I have long been engaged in peritoneal dialysis catheter placement, management of peritoneal dialysis catheter
Affiliated Hospital
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
Chief Physician, Professor, Doctoral Supervisor, Director of the Department of Nuclear Medicine, Renji Hospital.
Urology
Research Areas : Biological mechanisms and clinical translation of PET/CT imaging technology; integrated diagnosis and treatment of PSMA in prostate cancer. Cutting-Edge Technologies: Over 20 years of clinical experience in nuclear medicine molecular imaging; pioneered the application of PET/CT for the differential diagnosis, staging, and efficacy evaluation of malignant tumors; led research on the detection rate and lesion distribution characteristics of Ga-PSMA-11 PET/CT in patients with biochemical rec
Affiliated Hospital
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
Associate Chief Physician, Doctoral Supervisor
Urology
-Research areas : Multimodal PET/MR molecular imaging, AI-assisted PSMA lesion detection, and quantitative molecular imaging of tumors. - Cutting-edge technologies: PET/MR multi-parameter fusion imaging; AI-assisted automatic identification and quantitative analysis of PSMA-positive lesions. - Areas of expertise: Precise PET/MR assessment of prostate cancer, brain tumors, and neurodegenerative diseases. - Academic Highlights: Shanghai Pujiang Talent, Associate Editor of Integrated PET/MR Clinical Atlas; p
Affiliated Hospital
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
Chief Physician, Professor, Doctoral Supervisor, and Academic Leader of Nuclear Medicine at Renji Hospital.
Urology
Research Areas : Research and clinical applications in nuclear medicine and cardiology, including tumor metabolic mechanisms and molecular imaging techniques and equipment. Cutting-Edge Technologies: With over 40 years of experience in clinical and teaching work in nuclear medicine, I have conducted systematic research in areas such as integrated nuclear medicine diagnosis and treatment, and the application of artificial intelligence in precision medicine. I delivered a keynote speech entitled "Artificial
Affiliated Hospital
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
Chief Physician, Professor, Doctoral Supervisor, Director of Nephrology Department.
Urology
Research Areas : Diagnosis and treatment of acute and chronic glomerular diseases and renal insufficiency; early intervention for membranous nephropathy, minimal change disease, acute kidney injury, and hereditary kidney diseases. Cutting-Edge Technologies: Significant achievements in the molecular pathological mechanisms of glomerular diseases, particularly skilled in the detection of antiphospholipase A2 receptor antibodies and individualized immunosuppression protocols for membranous nephropathy; led t
Affiliated Hospital
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
Chief Physician, Level 2 Dr., Doctoral Supervisor. Vice President of Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, former Director of the Department of Urology
Urology
Standing Committee Member of the Chinese Urological Association, Chairman of the Shanghai Urological Association, Director of the Shanghai Urological Clinical Quality Control Center, Standing Committee Member of the Chinese Medical Doctor Association Urological Association, Deputy Leader of the Minimally Invasive Surgery Group of the Chinese Urological Association, Vice Chairman of the Urology Branch of the China International Exchange and Promotion Association for Medical and Health Care, Vice Chairman o
Affiliated Hospital
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
